Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: ADP 01611, NCI-2014-01584, UPCC 01611, NCT01350401
Gene and Vaccine Therapy in Treating Patients with Advanced Malignancies
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: 12-000153, NCI-2012-01548, 1203-1157, 41.12.0-h, NCT01697527
Laboratory Treated T-Cells in Treating Patients with NY-ESO-1 Expressing Metastatic or Locally Advanced Recurrent Solid Tumors or Malignant Meningioma
Phase: Phase II
Type: Treatment
Age: 18 to 66
Trial IDs: 13-C-0214, NCI-2015-00137, 130214, 1308-1249, P131300, RD-13-VII-07, NCT01967823
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients with Locally Advanced or Metastatic Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 16 and over
Trial IDs: 13-001624, NCI-2014-00221, NCT02070406
Start Over